Table 4.
Correlation between FAR and clinicopathological characteristics in gallbladder cancer patients n (%)
| Characteristics |
FAR |
P value | |
| ≤ 0.08 (n = 71) | > 0.08 (n = 83) | ||
| Age (yr) | |||
| ≤ 60 | 32 (20.8) | 24 (15.6) | 0.045 |
| > 60 | 39 (25.3) | 59 (38.3) | |
| Sex | |||
| Male | 30 (19.5) | 33 (21.4) | 0.870 |
| Female | 41 (26.6) | 50 (32.5) | |
| Cholecystolithiasis | |||
| Absent | 37 (24.0) | 42 (27.3) | 0.873 |
| Present | 34 (22.1) | 41 (26.6) | |
| Diabetes | |||
| Absent | 56 (36.4) | 60 (39.0) | 0.357 |
| Present | 15 (9.7) | 23 (14.9) | |
| Jaundice | |||
| Absent | 67 (43.5) | 62 (40.3) | < 0.001 |
| Present | 4 (2.6) | 21 (13.6) | |
| Blood groups | |||
| A | 22 (14.3) | 21 (13.6) | 0.148 |
| B | 28 (18.2) | 28 (18.2) | |
| AB | 1 (0.6) | 8 (5.2) | |
| O | 20 (13.0) | 26 (16.9) | |
| Pathological types | |||
| Adenosquamous carcinoma | 0 (0) | 3 (1.9) | 0.173 |
| Adenocarcinoma | 71 (46.1) | 79 (51.3) | |
| Papillocarcinoma | 0 (0) | 1 (0.6) | |
| Degree of differentiation | |||
| Poor | 18 (11.7) | 42 (27.3) | 0.002 |
| Moderate-well | 53 (34.4) | 41 (26.6) | |
| Resection margin status | |||
| Negative | 55 (35.7) | 41 (26.6) | < 0.001 |
| Positive | 16 (10.4) | 42 (27.3) | |
| Maximum tumor diameter (cm) | |||
| ≤ 2.45 | 37 (24.0) | 31 (20.1) | 0.075 |
| > 2.45 | 34 (22.1) | 52 (33.8) | |
| T stage | |||
| Tis-T1a | 8 (5.2) | 2 (1.3) | < 0.001 |
| T1b-T2b | 24 (15.6) | 5 (3.2) | |
| T3 | 36 (23.4) | 67 (43.5) | |
| T4 | 3 (1.9) | 9 (5.8) | |
| N stage | |||
| N0 | 48 (31.2) | 50 (32.5) | 0.623 |
| N1 | 19 (12.3) | 28 (18.2) | |
| N2 | 4 (2.6) | 5 (3.2) | |
| Distant metastasis | |||
| Absent | 68 (44.2) | 74 (48.1) | 0.145 |
| Present | 3 (1.9) | 9 (5.8) | |
| TNM stage | |||
| 0-Istage | 14 (9.1) | 2 (1.3) | < 0.001 |
| IIA-IIB stage | 14 (9.1) | 2 (1.3) | |
| IIIA-IIIB stage | 35 (22.7) | 57 (37.0) | |
| IVA-IVB stage | 8 (5.2) | 22 (14.3) | |
| CA199 (U/mL) | |||
| ≤ 39 | 43 (27.9) | 23 (14.9) | < 0.001 |
| > 39 | 28 (18.2) | 60 (39.0) | |
| Fibrinogen concentration (g/L) | |||
| ≤ 3.47g/L | 59 (38.3) | 16 (10.4) | < 0.001 |
| > 3.47 g/L | 12 (7.8) | 67 (43.5) | |
| Albumin levels (g/L) | |||
| ≤ 40.5g/L | 21 (13.6) | 55 (35.7) | < 0.001 |
| > 40.5 g/L | 50 (32.5) | 28 (18.2) | |